Swiss Re Tackles Longevity Drug Impact With Life Policy Advice
Insurance Journal - Aug 12, 2025
Swiss Re AG issued guidance for underwriters on how to assess life insurance applications of people who show signs of using medications for longevity purposes. Metformin, traditionally used to manage type 2 diabetes, and rapamycin, an immunosuppressant developed for organ …...
Recommended Articles
Posted: Apr 16, 2026
The medical officer for the Texas summer camp where 27 girls were killed in a flood last year testif...
Posted: Apr 16, 2026
Utah-based insurance broker Trucordia reports it has acquired the Paradiso Financial and Insurance S...
Posted: Apr 16, 2026
Inszone Insurance Services announced the acquisition of Insurance Resources Group, Inc. Located in O...